Florin Daniel P
SEC CIK 1402459 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LUNG | Pulmonx Corp | Dir | 133.9K | $171.4K | $46.4K | 8 | 2021-07-12 | 2026-06-05 |
Most active insiders at LUNG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | French Glendon E. III | Pres, CEO, Dir | — | $292.3K |
| 2 | Lehman David Aaron | GC | — | $88.5K |
| 3 | Radhakrishnan Srikanth | Chief Science, Techn. Off | — | $69.5K |
| 4 | Rose Geoffrey Beran | Chief Commercial Off | — | $51.1K |
| 5 | Florin Daniel P | Dir | — | $46.4K |
| 6 | Sullivan Tiffany | Dir | — | — |
| 7 | Melenikiotou Georgia | Dir | — | — |
| 8 | Sung Derrick | COO, CFO | — | — |
| 9 | Burns Thomas William | Dir | — | — |
| 10 | Mead Dana G Jr. | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-09 17:59 | 2026-06-05 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | A - Grant | $0.00 | +40.0K | 133.9K | +43% | $0 | |
| 2025-12-09 | 2025-12-08 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | S - Sale | $1.99 | -23.3K | 93.9K | -20% | -$46.4K | |
| 2025-06-05 | 2025-06-05 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | P - Purchase | $3.06 | +23.3K | 117.2K | +25% | +$71.4K | |
| 2025-06-04 | 2025-06-02 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | A - Grant | $0.00 | +37.2K | 93.9K | +65% | $0 | |
| 2024-06-05 | 2024-06-03 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | A - Grant | $0.00 | +15.2K | 41.0K | +59% | $0 | |
| 2023-06-02 | 2023-06-01 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | A - Grant | $0.00 | +12.6K | 25.8K | +96% | $0 | |
| 2022-06-03 | 2022-06-01 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | A - Grant | $0.00 | +5,600 | 13.1K | +74% | $0 | |
| 2021-07-13 | 2021-07-12 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | P - Purchase | $40.00 | +2,500 | 7,532 | +50% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations